Sarepta Therapeutics (SRPT) EBITDA Margin Growth (1y) (2013 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 3,609.00 |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 1,536.00 |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -957.00 |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 8,807.00 |
| 10 | Sarepta Therapeutics | 1.86 Bn | 1.17 Bn | 291.52 Mn | 31,483.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 31,483.00 |
| Dec 31, 2025 | -11,748.00 |
| Sep 30, 2025 | -5,289.00 |
| Jun 30, 2025 | 3,052.00 |
| Mar 31, 2025 | -23,364.00 |
| Dec 31, 2024 | 1,437.00 |
| Sep 30, 2024 | 2,011.00 |
| Jun 30, 2024 | 11,214.00 |
| Mar 31, 2024 | 21,170.00 |
| Dec 31, 2023 | 7,385.00 |
| Sep 30, 2023 | 11,218.00 |
| Jun 30, 2023 | 18.00 |
| Mar 31, 2023 | 27,522.00 |
| Dec 31, 2022 | 4,528.00 |
| Sep 30, 2022 | -9,896.00 |
| Jun 30, 2022 | -5,325.00 |
| Mar 31, 2022 | -36,474.00 |
| Dec 31, 2021 | 73,266.00 |
| Sep 30, 2021 | 84,815.00 |
| Jun 30, 2021 | 52,464.00 |
| Mar 31, 2021 | 1,408.00 |
| Dec 31, 2020 | -60,613.00 |
| Sep 30, 2020 | -74,602.00 |
| Jun 30, 2020 | -29,012.00 |
| Mar 31, 2020 | -3,997.00 |
| Dec 31, 2019 | -6,843.00 |
| Sep 30, 2019 | -3,069.00 |
| Jun 30, 2019 | -14,368.00 |
| Mar 31, 2019 | -3,280.00 |
| Dec 31, 2018 | -12,450.00 |
| Sep 30, 2018 | 695.00 |
| Jun 30, 2018 | 3,181.00 |
| Mar 31, 2018 | -57,011.00 |
| Dec 31, 2014 | -16.43 Mn |
| Sep 30, 2014 | -175,336.00 |
| Jun 30, 2014 | -66,491.00 |
| Mar 31, 2014 | 47,526.00 |
| Dec 31, 2013 | 51,019.00 |
| Sep 30, 2013 | -35,413.00 |
| Jun 30, 2013 | -71,730.00 |
| Mar 31, 2013 | -78,273.00 |